COVID-19 Vaccine: DCGI approves anti-COVID drug developed by DRDO
The Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories, Hyderabad, developed an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG).
The Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories, Hyderabad, developed an anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG).